Results 181 to 190 of about 778,919 (247)

mRNA vaccine expressing enterovirus D68 virus-like particles induces potent neutralizing antibodies and protects against infection. [PDF]

Mol Ther Nucleic Acids
Kunishima Y, Senpuku K, Kataoka-Nakamura C, Hirai T, Yoshioka Y.   +4 more
europepmc   +1 more source

Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki Forest virus as a genetic adjuvant. [PDF]

J Gen Virol
Dislers A, Nilova O, Jansons J, Skrastina D, Bogans J, Petrovskis I, Spunde K, Stepanovs R, Kazaks A, Zajakina A, Sominskaya I.   +10 more
europepmc   +1 more source

Impact of specific productivity and operation mode upon the biophysical properties of HIV-1 Gag-based virus-like particles. [PDF]

Appl Microbiol Biotechnol
Pérez-Rubio P, Lorenzo Romero E, Casas J, Díaz-Maneh A, Gòdia F, Cervera L, Lavado-García J.   +6 more
europepmc   +1 more source

Protective Efficacy Induced by Virus-like Particles Expressing Dense Granule Protein 5 of <i>Toxoplasma gondii</i>. [PDF]

Vaccines (Basel)
Heo SI, Kang HJ, Mao J, Yang ZS, Ahmed MA, Quan FS.   +5 more
europepmc   +1 more source

Neo-antigen tumor vaccination depends on CD4-licensing conveyed by adeno-associated virus like particles. [PDF]

Mol Ther
Neukirch L, Uhrig-Schmidt S, von Werthern K, Tuch A, Kraske JA, Lyu Y, Lenoir B, Eichmüller SB, Meyer M, Zörnig I, Jäger D, Schmidt P.   +11 more
europepmc   +1 more source

Erratum to "Dual-Stage Cross-Flow Filtration: Integrated Capture and Purification of Virus-Like Particles". [PDF]

Biotechnol Bioeng
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Virus-Like Particles

CABI Compendium, 2022
This datasheet on virus-like particles covers Identity, Distribution.
P. Pumpens, P. Pushko, Philippe le Mercier   +2 more
semanticscholar   +2 more sources

Enzyme Stabilization by Virus-Like Particles.

Biochemistry, 2020
The properties of enzymes packaged within the coat protein shell of virus-like particles (VLPs) were studied to provide a comprehensive assessment of such factors. Such entrainment did not seem to perturb enzyme function, but it did significantly enhance
Soumen Das, Liangjun Zhao, Kristen Elofson, M. G. Finn   +3 more
semanticscholar   +3 more sources

Virus-like particles for drug delivery: a review of methods and applications.

Current Opinion in Biotechnology, 2022
Virus-like particles (VLPs) are self-assembling protein nanoparticles that have great promise as vectors for drug delivery. VLPs are derived from viruses but retain none of their infection or replication capabilities. These protein particles have defined
Bon C. Ikwuagwu, D. Tullman-Ercek
semanticscholar   +1 more source

Hybrid Ty Virus-Like Particles

International Reviews of Immunology, 1994
Vaccines need to activate antigen presenting cells, overcome genetic restriction in T-cell responses and elicit both T and B memory cells. In order to produce recombinant vaccines which can do this, considerable effort has been put into developing particulate antigen presentation systems to generate polyvalent, high molecular weight antigens which ...
S E, Adams, N R, Burns, G T, Layton, A J, Kingsman   +3 more
openaire   +2 more sources